Subject
Infectious Diseases,Microbiology (medical)
Reference14 articles.
1. The effect of molnupiravir on post-acute outcome of COVID-19 survivor;Hsu;J Infect,2023
2. Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies;Yamasoba;Lancet Infect Dis,2022
3. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants;Westendorf;Cell Rep,2022
4. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants;Wang;Cell,2023
5. Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19;Dougan;medRxiv,2022
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献